The evaluaton of prevalence rate of p53 antigen expression in cutaneous malignant melanoma and it′s relation to tumor thickness
P<sub>53 </sub>tumor suppressor gene mutation is one of the most common genetic alteration in human malignancies. This study was done to determine the prevalence of the P<sub>53 </sub>antigen expression by sex, age, type of melanoma, thickness of the lesion and site of the an...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2005-01-01
|
Series: | Indian Journal of Dermatology |
Subjects: | |
Online Access: | http://www.e-ijd.org/article.asp?issn=0019-5154;year=2005;volume=50;issue=3;spage=133;epage=135;aulast=Faghihi |
id |
doaj-6b35b3bd2863401a92db1207ba156133 |
---|---|
record_format |
Article |
spelling |
doaj-6b35b3bd2863401a92db1207ba1561332020-11-24T23:01:04ZengWolters Kluwer Medknow PublicationsIndian Journal of Dermatology0019-51542005-01-01503133135The evaluaton of prevalence rate of p53 antigen expression in cutaneous malignant melanoma and it′s relation to tumor thicknessFaghihi GitaRadan MohammadrezaGhanei NargesRajabi ParvinTaheri DianaP<sub>53 </sub>tumor suppressor gene mutation is one of the most common genetic alteration in human malignancies. This study was done to determine the prevalence of the P<sub>53 </sub>antigen expression by sex, age, type of melanoma, thickness of the lesion and site of the antigen expression either cytoplasmic or nuclear.<i> </i> Paraffin embeded block of 50 patients (45 primary and metastatic)with documented diagnosis of melanoma deparaffinized and immuno stained with DO-7 monoclonal antibody. The lesions were divided depending on the degree of the staining as follow: 1. no staining, 2. mild (less than 10%), 3. moderate (10%-50% staining), 4. severe (more than 50%). Fifty four percent of evaluated patients were female and 46% were male. Forty percent of lesions were graded as no staining, 36% of lesions showed mild staining, 14% moderate and 10% severe staining site of expression was excusively in the cytoplasm. There was no meaningful statistical deference between severity of staining and the age group, sex, type and thickness of melanoma. (p value was 0.532, 0.488, 0.626, 0.954 respectively). http://www.e-ijd.org/article.asp?issn=0019-5154;year=2005;volume=50;issue=3;spage=133;epage=135;aulast=FaghihiMelanomaP<sub>53 </sub>antigen |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Faghihi Gita Radan Mohammadreza Ghanei Narges Rajabi Parvin Taheri Diana |
spellingShingle |
Faghihi Gita Radan Mohammadreza Ghanei Narges Rajabi Parvin Taheri Diana The evaluaton of prevalence rate of p53 antigen expression in cutaneous malignant melanoma and it′s relation to tumor thickness Indian Journal of Dermatology Melanoma P<sub>53 </sub>antigen |
author_facet |
Faghihi Gita Radan Mohammadreza Ghanei Narges Rajabi Parvin Taheri Diana |
author_sort |
Faghihi Gita |
title |
The evaluaton of prevalence rate of p53 antigen expression in cutaneous malignant melanoma and it′s relation to tumor thickness |
title_short |
The evaluaton of prevalence rate of p53 antigen expression in cutaneous malignant melanoma and it′s relation to tumor thickness |
title_full |
The evaluaton of prevalence rate of p53 antigen expression in cutaneous malignant melanoma and it′s relation to tumor thickness |
title_fullStr |
The evaluaton of prevalence rate of p53 antigen expression in cutaneous malignant melanoma and it′s relation to tumor thickness |
title_full_unstemmed |
The evaluaton of prevalence rate of p53 antigen expression in cutaneous malignant melanoma and it′s relation to tumor thickness |
title_sort |
evaluaton of prevalence rate of p53 antigen expression in cutaneous malignant melanoma and it′s relation to tumor thickness |
publisher |
Wolters Kluwer Medknow Publications |
series |
Indian Journal of Dermatology |
issn |
0019-5154 |
publishDate |
2005-01-01 |
description |
P<sub>53 </sub>tumor suppressor gene mutation is one of the most common genetic alteration in human malignancies. This study was done to determine the prevalence of the P<sub>53 </sub>antigen expression by sex, age, type of melanoma, thickness of the lesion and site of the antigen expression either cytoplasmic or nuclear.<i> </i> Paraffin embeded block of 50 patients (45 primary and metastatic)with documented diagnosis of melanoma deparaffinized and immuno stained with DO-7 monoclonal antibody. The lesions were divided depending on the degree of the staining as follow: 1. no staining, 2. mild (less than 10%), 3. moderate (10%-50% staining), 4. severe (more than 50%). Fifty four percent of evaluated patients were female and 46% were male. Forty percent of lesions were graded as no staining, 36% of lesions showed mild staining, 14% moderate and 10% severe staining site of expression was excusively in the cytoplasm. There was no meaningful statistical deference between severity of staining and the age group, sex, type and thickness of melanoma. (p value was 0.532, 0.488, 0.626, 0.954 respectively). |
topic |
Melanoma P<sub>53 </sub>antigen |
url |
http://www.e-ijd.org/article.asp?issn=0019-5154;year=2005;volume=50;issue=3;spage=133;epage=135;aulast=Faghihi |
work_keys_str_mv |
AT faghihigita theevaluatonofprevalencerateofp53antigenexpressionincutaneousmalignantmelanomaanditx2032srelationtotumorthickness AT radanmohammadreza theevaluatonofprevalencerateofp53antigenexpressionincutaneousmalignantmelanomaanditx2032srelationtotumorthickness AT ghaneinarges theevaluatonofprevalencerateofp53antigenexpressionincutaneousmalignantmelanomaanditx2032srelationtotumorthickness AT rajabiparvin theevaluatonofprevalencerateofp53antigenexpressionincutaneousmalignantmelanomaanditx2032srelationtotumorthickness AT taheridiana theevaluatonofprevalencerateofp53antigenexpressionincutaneousmalignantmelanomaanditx2032srelationtotumorthickness AT faghihigita evaluatonofprevalencerateofp53antigenexpressionincutaneousmalignantmelanomaanditx2032srelationtotumorthickness AT radanmohammadreza evaluatonofprevalencerateofp53antigenexpressionincutaneousmalignantmelanomaanditx2032srelationtotumorthickness AT ghaneinarges evaluatonofprevalencerateofp53antigenexpressionincutaneousmalignantmelanomaanditx2032srelationtotumorthickness AT rajabiparvin evaluatonofprevalencerateofp53antigenexpressionincutaneousmalignantmelanomaanditx2032srelationtotumorthickness AT taheridiana evaluatonofprevalencerateofp53antigenexpressionincutaneousmalignantmelanomaanditx2032srelationtotumorthickness |
_version_ |
1725640790426779648 |